I meant widespread use after a randomised trial has been conducted. I thought I made that clear by quoting the part in which they advocate a...
In the original study they stated. “This study shows that cyclophosphamide intervention is feasible for ME/CFS patients. The growing evidence for...
If Siobhan was the only case I would also be skeptical, but her case needs to be viewed within the larger body of evidence. 22/40 trial...
A placebo response is much less plausible in a patient who has tried and completely failed multiple strong (and in some cases expensive)...
Siobhan has kept me updated on her treatment journey. This is my summary which I wrote for another group and she has checked and approved. I hope...
Thanks for clarifying. As you said, your patients had much more than six doses. It is also likely they had a history of other immunosuppressive...
I don’t know. We will find out soon when they publish the full paper.
Please could you clarify your first point. If the natural history of ME is too unpredictable for researchers to use ME patients as controls, then...
Another common argument against cyclophosphamide is the risk of infertility and early menopause. Male fertility risk is significant, but can be...
There are many reasons why a phase three trial of cyclophosphamide should be pursued despite the risks and unpleasant side effects of this drug....
These are the six year rituximab and cyclophosphamide follow up slides from Fluge’s talk at the 2023 Charite conference. I am posting them because...
Separate names with a comma.
